Počet záznamov: 1
afatinib
SYS d000077716 LBL 00000nx^^^2200181-^^45^^ 005 20240119195331.9 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a afatinib $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2019 (2007) $8 eng 330 1-
$a A quinazoline and butenamide derivative that acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. $8 eng 450 $a afatinib dimaleát $5 e $8 slo 450 $a afatinib maleát $5 e $8 slo 450 $a Gilotrif $5 e $8 slo 686 $a D02.065.132 686 $a D03.633.100.786.188 750 $a Afatinib $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190319 980 $x M
Počet záznamov: 1